Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer
US10426843B2 · kind B2 · utility
0Cited by
7References
12Claims
0Family size
Inventors
Key dates
| Filing date | May 4, 2017 |
| Grant date | Oct 1, 2019 |
| Priority date | — |
| Expiry date | May 4, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject matter disclosed herein relates generally to cancer therapy and to anticancer compounds and imaging agents. More specifically, the subject matter disclosed herein relates to agents that target DOR and their use in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.